Market access agreements for pharmaceuticals in Europe: diversity of approaches and underlying concepts

Abstract

BACKGROUND Market Access Agreements (MAA) between pharmaceutical industry and health care payers have been proliferating in Europe in the last years. MAA can be simple discounts from the list price or very sophisticated schemes with inarguably high administrative burden. DISCUSSION We distinguished and defined from the health care payer perspective three… (More)
DOI: 10.1186/1472-6963-11-259

Topics

2 Figures and Tables

Cite this paper

@inproceedings{Jarosawski2011MarketAA, title={Market access agreements for pharmaceuticals in Europe: diversity of approaches and underlying concepts}, author={Szymon Jarosławski and Mondher Toumi}, booktitle={BMC health services research}, year={2011} }